CR11270A - Pirimidinas biciclicas fusionadas - Google Patents
Pirimidinas biciclicas fusionadasInfo
- Publication number
- CR11270A CR11270A CR11270A CR11270A CR11270A CR 11270 A CR11270 A CR 11270A CR 11270 A CR11270 A CR 11270A CR 11270 A CR11270 A CR 11270A CR 11270 A CR11270 A CR 11270A
- Authority
- CR
- Costa Rica
- Prior art keywords
- fusioned
- pyrimidins
- bicycle
- tautomers
- stereoisomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Compuestos de formula (I) los tautomeros o los estereoisomeros de estos o las sales de estos, donde el anillo B y la pirimidina a la que esta fusionado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1572MU2007 | 2007-08-14 | ||
EP07118736A EP2050748A1 (en) | 2007-10-18 | 2007-10-18 | Novel fused pyrimidines |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11270A true CR11270A (es) | 2010-05-19 |
Family
ID=40153211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11270A CR11270A (es) | 2007-08-14 | 2010-02-12 | Pirimidinas biciclicas fusionadas |
Country Status (38)
Country | Link |
---|---|
US (2) | US7776864B2 (es) |
EP (1) | EP2188291B1 (es) |
JP (1) | JP5344637B2 (es) |
KR (1) | KR20100053556A (es) |
CN (1) | CN101778851B (es) |
AR (1) | AR067945A1 (es) |
AU (1) | AU2008288392B2 (es) |
BR (1) | BRPI0815207A2 (es) |
CA (1) | CA2694058C (es) |
CL (1) | CL2008002398A1 (es) |
CO (1) | CO6260077A2 (es) |
CR (1) | CR11270A (es) |
CY (1) | CY1113486T1 (es) |
DK (1) | DK2188291T3 (es) |
DO (1) | DOP2010000058A (es) |
EA (1) | EA020996B1 (es) |
EC (1) | ECSP109964A (es) |
ES (1) | ES2396177T3 (es) |
HK (1) | HK1146273A1 (es) |
HN (1) | HN2010000313A (es) |
HR (1) | HRP20121022T1 (es) |
IL (1) | IL203163A (es) |
MA (1) | MA31608B1 (es) |
MX (1) | MX2010001746A (es) |
MY (1) | MY169738A (es) |
NZ (1) | NZ583267A (es) |
PA (1) | PA8793201A1 (es) |
PE (1) | PE20090944A1 (es) |
PL (1) | PL2188291T3 (es) |
PT (1) | PT2188291E (es) |
RS (1) | RS52559B (es) |
SI (1) | SI2188291T1 (es) |
SV (1) | SV2010003483A (es) |
TN (1) | TN2010000070A1 (es) |
TW (1) | TWI439272B (es) |
UA (1) | UA99735C2 (es) |
UY (1) | UY31293A1 (es) |
WO (1) | WO2009021992A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2009003972A (es) * | 2006-10-19 | 2009-04-27 | Takeda Pharmaceutical | Compuesto de indol. |
EP2188291B1 (en) | 2007-08-14 | 2012-09-19 | Bayer Pharma Aktiengesellschaft | Fused bicyclic pyrimidines |
WO2009155121A2 (en) | 2008-05-30 | 2009-12-23 | Amgen Inc. | Inhibitors of pi3 kinase |
WO2010091808A1 (en) | 2009-02-13 | 2010-08-19 | Bayer Schering Pharma Aktiengesellschaft | Fused pyrimidines |
WO2010091824A1 (en) * | 2009-02-13 | 2010-08-19 | Bayer Schering Pharma Aktiengesellschaft | Fused pyrimidines as akt inhibitors |
EP2413932A4 (en) * | 2009-04-01 | 2012-09-19 | Merck Sharp & Dohme | INHIBITORS OF AKT ACTIVITY |
TW201103943A (en) | 2009-04-27 | 2011-02-01 | Shionogi & Co | Urea derivative having pi3k inhibitory activity |
US20130184273A1 (en) * | 2010-07-13 | 2013-07-18 | Bayer Intellectual Property Gmbh | Bicyclic pyrimidines |
CN103384670B (zh) | 2010-07-28 | 2016-05-25 | 拜耳知识产权有限责任公司 | 取代的咪唑并[1,2-b]哒嗪 |
HUE026323T2 (en) | 2011-04-07 | 2016-05-30 | Bayer Ip Gmbh | Imidazopyridazines as AKT kinase inhibitors |
RU2644769C2 (ru) | 2013-01-23 | 2018-02-14 | Астразенека Аб | Химические соединения |
US20160272861A1 (en) * | 2013-03-15 | 2016-09-22 | Bayer Cropscience Lp | Compositions, additives, and methods for mitigating or controlling seed dust |
US20140274685A1 (en) | 2013-03-15 | 2014-09-18 | Bayer Cropscience Lp | Compositions, additives, and methods for mitigating or controlling seed dust |
MX2020002869A (es) | 2017-09-15 | 2020-07-24 | Aduro Biotech Inc | Compuestos de pirazolopirimidinona y usos de los mismos. |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1592624A (zh) | 2000-06-30 | 2005-03-09 | 惠氏公司 | 被取代的三唑并嘧啶类化合物作为抗癌药 |
US7449488B2 (en) * | 2002-06-04 | 2008-11-11 | Schering Corporation | Pyrazolopyrimidines as protein kinase inhibitors |
JP4616831B2 (ja) | 2003-04-24 | 2011-01-19 | メルク・シャープ・エンド・ドーム・コーポレイション | Akt活性の阻害剤 |
JP2007532558A (ja) | 2004-04-09 | 2007-11-15 | メルク エンド カムパニー インコーポレーテッド | Akt活性の阻害剤 |
AR050188A1 (es) * | 2004-08-03 | 2006-10-04 | Uriach Y Compania S A J | Compuestos heterociclicos condensados utiles en terapia como inhibidores de quinasas p38 y composiciones farmaceuticas que los contienen |
JP2008510823A (ja) * | 2004-08-23 | 2008-04-10 | メルク エンド カムパニー インコーポレーテッド | Akt活性阻害剤 |
EP1827436A4 (en) | 2004-12-15 | 2011-08-10 | Merck Sharp & Dohme | ACTIVITY INHIBITORS AKT |
JP5274842B2 (ja) | 2004-12-28 | 2013-08-28 | エグゼリクシス, インコーポレイテッド | 免疫疾患、炎症疾患および増殖疾患の処置のためのセリン−スレオニンキナーゼモジュレーター(p70S6K、Akt−1およびAkt−2)としての[1H−ピペラゾ[3,4−d]ピリミジン−4−イル]−ピペラジンまたは[1H−ピペラゾ[3,4−d]ピリミジン−4−イル]−ピペラジン化合物 |
WO2006091395A2 (en) | 2005-02-14 | 2006-08-31 | Merck & Co., Inc. | Inhibitors of akt activity |
CA2610888C (en) | 2005-06-10 | 2011-02-08 | Merck & Co., Inc. | Inhibitors of akt activity |
EP2188291B1 (en) | 2007-08-14 | 2012-09-19 | Bayer Pharma Aktiengesellschaft | Fused bicyclic pyrimidines |
WO2010091808A1 (en) * | 2009-02-13 | 2010-08-19 | Bayer Schering Pharma Aktiengesellschaft | Fused pyrimidines |
-
2008
- 2008-08-14 EP EP08787224A patent/EP2188291B1/en active Active
- 2008-08-14 NZ NZ583267A patent/NZ583267A/en not_active IP Right Cessation
- 2008-08-14 JP JP2010520586A patent/JP5344637B2/ja not_active Expired - Fee Related
- 2008-08-14 MX MX2010001746A patent/MX2010001746A/es active IP Right Grant
- 2008-08-14 EA EA201000298A patent/EA020996B1/ru not_active IP Right Cessation
- 2008-08-14 WO PCT/EP2008/060690 patent/WO2009021992A2/en active Application Filing
- 2008-08-14 CL CL2008002398A patent/CL2008002398A1/es unknown
- 2008-08-14 MY MYPI2010000150A patent/MY169738A/en unknown
- 2008-08-14 RS RS20120556A patent/RS52559B/en unknown
- 2008-08-14 PA PA20088793201A patent/PA8793201A1/es unknown
- 2008-08-14 SI SI200830848T patent/SI2188291T1/sl unknown
- 2008-08-14 UY UY31293A patent/UY31293A1/es not_active Application Discontinuation
- 2008-08-14 PE PE2008001378A patent/PE20090944A1/es not_active Application Discontinuation
- 2008-08-14 AU AU2008288392A patent/AU2008288392B2/en not_active Ceased
- 2008-08-14 US US12/191,703 patent/US7776864B2/en not_active Expired - Fee Related
- 2008-08-14 DK DK08787224.8T patent/DK2188291T3/da active
- 2008-08-14 BR BRPI0815207A patent/BRPI0815207A2/pt not_active IP Right Cessation
- 2008-08-14 PT PT87872248T patent/PT2188291E/pt unknown
- 2008-08-14 UA UAA201002746A patent/UA99735C2/uk unknown
- 2008-08-14 TW TW097131066A patent/TWI439272B/zh not_active IP Right Cessation
- 2008-08-14 KR KR1020107003246A patent/KR20100053556A/ko active IP Right Grant
- 2008-08-14 PL PL08787224T patent/PL2188291T3/pl unknown
- 2008-08-14 CN CN2008801031086A patent/CN101778851B/zh not_active Expired - Fee Related
- 2008-08-14 CA CA2694058A patent/CA2694058C/en not_active Expired - Fee Related
- 2008-08-14 ES ES08787224T patent/ES2396177T3/es active Active
- 2008-08-15 AR ARP080103562A patent/AR067945A1/es unknown
-
2010
- 2010-01-06 IL IL203163A patent/IL203163A/en not_active IP Right Cessation
- 2010-02-12 HN HN2010000313A patent/HN2010000313A/es unknown
- 2010-02-12 MA MA32617A patent/MA31608B1/fr unknown
- 2010-02-12 SV SV2010003483A patent/SV2010003483A/es unknown
- 2010-02-12 CR CR11270A patent/CR11270A/es unknown
- 2010-02-12 EC EC2010009964A patent/ECSP109964A/es unknown
- 2010-02-12 DO DO2010000058A patent/DOP2010000058A/es unknown
- 2010-02-12 CO CO10015919A patent/CO6260077A2/es active IP Right Grant
- 2010-02-12 TN TNP2010000070A patent/TN2010000070A1/fr unknown
- 2010-03-25 US US12/731,880 patent/US8614218B2/en not_active Expired - Fee Related
-
2011
- 2011-01-14 HK HK11100395.8A patent/HK1146273A1/xx not_active IP Right Cessation
-
2012
- 2012-12-12 HR HRP20121022AT patent/HRP20121022T1/hr unknown
- 2012-12-13 CY CY20121101220T patent/CY1113486T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11270A (es) | Pirimidinas biciclicas fusionadas | |
CY1112102T1 (el) | Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1 | |
CR11271A (es) | Imidazoles fusionados para el tratamiento del cancer | |
CO6321272A2 (es) | Fosfatos ciclicos de nucleosidos. | |
CU23834B1 (es) | Compuestos de pirazolo [3,4-d] pirimidinona y sus derivados para la inhibición pde9 | |
CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
UY28290A1 (es) | Compuestos farmacéuticos novedosos | |
CU20090017A7 (es) | Peptidomimeticos de smac utiles como inhibidores de proteinas de apoptosis (iap) | |
NI200900032A (es) | Compuestos de pirido (2, 3-d) pirimidinonay su uso como inhibidores de pi3 | |
CO6491116A2 (es) | Derivados de 5-fluoropirimidinona | |
GT200500286A (es) | Analogos de anilino-pirimidina | |
CO6491082A2 (es) | Derivados de n 1-sulfonil-5-fluoropirimidinona | |
NI201000059A (es) | Inhibidores de la cinasa c-fms. | |
UY29927A1 (es) | Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones | |
DOP2011000174A (es) | Compuestos organicos | |
SV2011003809A (es) | Derivados de heteroarilo como inhibidores de dgat1 | |
EA200802380A1 (ru) | Совместные кристаллы пирролидинонов | |
NI200900155A (es) | COMPUESTOS DE 2-AMINO PIRIMIDINA. Caso: PC 33441A | |
UY29070A1 (es) | Enantiómeros de heterocíclicos fusionados y sus usos | |
EA201100994A1 (ru) | Способ получения производных бисфуранового спирта, соединения, соль, фармацевтическая композиция на ее основе, способ лечения или профилактики ретровирусных инфекций с ее помощью | |
EA200900946A1 (ru) | Новый способ синтеза агомелатина | |
ATE517869T1 (de) | Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon | |
CR11463A (es) | Compuestos de piridilmetil-sulfonamida | |
ECSP12011652A (es) | Derivados de 5-fluoro-2-oxopirimidinona-1 (2h)-carboxamida substituida-n1 | |
UY30788A1 (es) | Compuestos quimicos |